• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Training in Post-authorization Pharmacovigilance.上市后药物警戒培训
Perspect Clin Res. 2010 Apr;1(2):70-5.
2
Strengthening and rationalizing pharmacovigilance in the EU: where is Europe heading to? A review of the new EU legislation on pharmacovigilance.加强和合理化欧盟的药物警戒:欧洲将走向何方?对新的欧盟药物警戒立法的审查。
Drug Saf. 2011 Mar 1;34(3):187-97. doi: 10.2165/11586620-000000000-00000.
3
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
4
Pharmacovigilance activities in 55 low- and middle-income countries: a questionnaire-based analysis.55 个中低收入国家的药物警戒活动:基于问卷调查的分析。
Drug Saf. 2010 Aug 1;33(8):689-703. doi: 10.2165/11536390-000000000-00000.
5
[A proposal for reforming psychologists' training in France and in the European Union].[关于法国及欧盟心理学家培训改革的一项提议]
Encephale. 2009 Feb;35(1):18-24. doi: 10.1016/j.encep.2007.11.008. Epub 2008 Apr 2.
6
Training Augmented Intelligent Capabilities for Pharmacovigilance: Applying Deep-learning Approaches to Individual Case Safety Report Processing.培养用于药物警戒的增强智能能力:将深度学习方法应用于个体病例安全报告处理
Pharmaceut Med. 2018;32(6):391-401. doi: 10.1007/s40290-018-0251-9. Epub 2018 Oct 13.
7
Pharmacovigilance in Israel - tools, processes, and actions.以色列的药物警戒——工具、流程与行动
Isr J Health Policy Res. 2017 Aug 1;6(1):29. doi: 10.1186/s13584-017-0154-3.
8
[Interpretation of Guidelines on Good Pharmacovigilance Practices for European Union].[欧盟药品不良反应监测规范解读]
Zhongguo Zhong Yao Za Zhi. 2013 Sep;38(18):2963-8.
9
Pharmacovigilance in pharmaceutical companies: An overview.制药公司的药物警戒:概述
J Pharmacol Pharmacother. 2013 Dec;4(Suppl 1):S33-7. doi: 10.4103/0976-500X.120945.
10
The Patient's Voice in Pharmacovigilance: Pragmatic Approaches to Building a Patient-Centric Drug Safety Organization.药物警戒中患者的声音:构建以患者为中心的药物安全组织的务实方法。
Drug Saf. 2016 Sep;39(9):779-85. doi: 10.1007/s40264-016-0426-9.

引用本文的文献

1
Training and education in pharmacovigilance: The experience from the Pharmacovigilance Programme of India.药物警戒方面的培训与教育:来自印度药物警戒计划的经验。
Indian J Pharmacol. 2024 Sep 1;56(5):348-357. doi: 10.4103/ijp.ijp_638_22. Epub 2024 Dec 16.

本文引用的文献

1
International Conference on Harmonisation; guidance on Addendum to E2C Clinical Safety Data Management: Periodic Safety Update Reports for Marketed Drugs; availability. Notice.国际协调会议;《E2C临床安全数据管理附录:已上市药品定期安全更新报告》指南;可获取性。通知。
Fed Regist. 2004 Feb 5;69(24):5551-2.

上市后药物警戒培训

Training in Post-authorization Pharmacovigilance.

作者信息

Ahuja Vivek, Sharma Varun

机构信息

Director-Clinical Operations, CDM & Pharmacovigilance, GVK Biosciences Private Limited.

出版信息

Perspect Clin Res. 2010 Apr;1(2):70-5.

PMID:21829787
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3148615/
Abstract

Post-authorization pharmacovigilance refers to all the activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problems, from the time a product gets the authorization to be marketed in a territory. The ultimate objective of pharmacovigilance is patient safety. To ensure this, any responsible pharmaceutical company will readily vouch for the importance of all these activities, each requiring specific training for efficient and effective execution. Having a well planned job specific training curriculum can help the organization realize its goals and objectives by covering the gaps between current and desired job performance levels and existing competencies of its employees. Apart from this, trainings can help in problem solving, increasing productivity and prepare for and respond to future changes in the organization or job duties. As the pharmaceutical business continues to grow, increasing numbers of skilled people are required to manage resultant increase in pharmacovigilance activities to remain compliant. Thus, the need for training qualified resources to develop into highly skilled pharmacovigilance professionals is the need of the hour. Currently, the supply-demand situation for skilled manpower is highly skewed in favor of the demand, as this field is relatively new in India and elsewhere. It is interesting to note that not many resources, be it internet, literature or books, are available specifically addressing the need of the industry to guide them on training requirements to set up and maintain a competent pharmacovigilance department. This article aims to present a comprehensive perspective on the trainings required in the post authorization scenario pertaining to pharmacovigilance activities and suggest ways to manage these in an efficient way so as to be compliant with the global norms and best practices.

摘要

上市后药物警戒是指从产品在某一地区获得上市许可之时起,与检测、评估、理解和预防不良反应或任何其他药物相关问题有关的所有活动。药物警戒的最终目标是患者安全。为确保这一点,任何负责任的制药公司都会欣然认可所有这些活动的重要性,每项活动都需要进行特定培训才能高效且有效地执行。制定一个精心规划的针对特定工作的培训课程,通过弥补员工当前工作表现水平与期望水平之间以及现有能力之间的差距,能够帮助组织实现其目标。除此之外,培训有助于解决问题、提高生产力,并为组织或工作职责的未来变化做好准备并做出应对。随着制药业务的持续增长,需要越来越多的技术人员来管理因药物警戒活动增加而产生的工作,以保持合规。因此,培养合格资源成为高技能药物警戒专业人员的需求迫在眉睫。目前,由于该领域在印度和其他地方相对较新,熟练劳动力的供需情况严重偏向需求方。值得注意的是,专门针对该行业需求以指导其培训要求以建立和维持一个称职的药物警戒部门的资源,无论是互联网、文献还是书籍,都并不多。本文旨在全面阐述上市后药物警戒活动场景下所需的培训,并提出有效管理这些培训的方法,以便符合全球规范和最佳实践。